Kirkegaard C, Norlem N, Lauridsen U B, Bjorum N
Acta Psychiatr Scand. 1975 Sep;52(3):170-7. doi: 10.1111/j.1600-0447.1975.tb00034.x.
Thyrotropin-releasing hormone (TRH) stimulation tests were performed in 19 patients with endogenous depression before treatment and when they had apparently recovered following antidepressive treatment. An increase in the maximal serum thyrotropin (TSH) response to TRH of more than 2.0 muU/ml was found in all of ten patients who did not relapse, while such an increase was found in only one of nine patients who did relapse within 6 months. I. e., a correct prognosis was possible in 94.7% (95% confidence limits 74.0 - 99.9%). Through significant changes were found in serum thyroxin (T4), free T4 index, serum triiodothyronine (T3) and free T3 index, these findings were of no prognostic value.
对19例内源性抑郁症患者在治疗前及抗抑郁治疗明显康复后进行促甲状腺激素释放激素(TRH)刺激试验。在10例未复发的患者中,所有人血清促甲状腺激素(TSH)对TRH的最大反应增加超过2.0 μU/ml,而在6个月内复发的9例患者中,只有1例出现这种增加。也就是说,94.7%(95%置信区间74.0 - 99.9%)的患者可以做出正确的预后判断。虽然血清甲状腺素(T4)、游离T4指数、血清三碘甲状腺原氨酸(T3)和游离T3指数有显著变化,但这些结果无预后价值。